Molina Healthcare (NYSE:MOH) Posts Quarterly Earnings Results, Beats Estimates By $0.10 EPS

Molina Healthcare (NYSE:MOH) announced its quarterly earnings results on Wednesday. The company reported $0.89 EPS for the quarter, beating the consensus estimate of $0.79 by $0.10, FiscalAI reports. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%. The firm had revenue of $11.08 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same quarter last year, the firm posted $1.84 earnings per share. The business’s revenue for the quarter was down 3.4% on a year-over-year basis.

Molina Healthcare Trading Down 2.2%

Shares of Molina Healthcare stock opened at $214.79 on Thursday. The firm has a 50-day simple moving average of $200.50 and a two-hundred day simple moving average of $195.51. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68. Molina Healthcare has a fifty-two week low of $121.06 and a fifty-two week high of $244.89. The company has a market cap of $11.21 billion, a P/E ratio of -1,193.21, a price-to-earnings-growth ratio of 31.50 and a beta of 0.78.

More Molina Healthcare News

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Molina reported third-quarter adjusted earnings of $0.89 per share, exceeding consensus estimates, while revenue of $11.08 billion also topped expectations of approximately $10.86 billion. Molina Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: Management reaffirmed its 2026 outlook, including approximately $42 billion in premium revenue and at least $2.38 in GAAP earnings per diluted share. Operating cash flow reached $629 million through the first nine months of the year. Molina Reports Third-Quarter GAAP EPS
• Neutral Sentiment: The earnings beat was partly offset by a difficult comparison: adjusted EPS declined from $1.84 a year ago, while GAAP EPS was $0.73 versus $1.51 previously. The company’s medical care ratio also edged higher to 92.9% from 92.6%, indicating ongoing cost pressure. Molina Healthcare Q3 Adjusted Earnings and Revenue Fall
• Negative Sentiment: GAAP net income fell 52% to $38 million from $79 million a year earlier. Premium revenue decreased roughly 4%, and membership fell to about 4.9 million, with lower Medicaid and Marketplace enrollment weighing on results. Molina Healthcare Posts Lower Third-Quarter Profit and Revenue
• Negative Sentiment: Investors remain concerned about the estimated 2026 earnings burden from implementing Molina’s Florida Medicaid contract and underperformance in its traditional Medicare Advantage Part D product. Molina plans to exit the traditional MAPD product in 2027, underscoring pressure on near-term profitability. Molina Healthcare Slides Amid Margin Pressure

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on MOH shares. Royal Bank Of Canada cut their price target on shares of Molina Healthcare from $248.00 to $218.00 and set a “sector perform” rating on the stock in a report on Friday, July 24th. Truist Financial decreased their price objective on Molina Healthcare from $250.00 to $225.00 and set a “hold” rating for the company in a report on Friday, July 24th. Zacks Research downgraded Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 12th. Wall Street Zen downgraded Molina Healthcare from a “hold” rating to a “sell” rating in a research note on Sunday, October 4th. Finally, Weiss Ratings raised Molina Healthcare from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday. Three investment analysts have rated the stock with a Buy rating, twelve have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Molina Healthcare currently has a consensus rating of “Hold” and a consensus target price of $202.44.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed-care company that provides health insurance and related services primarily through government-sponsored programs. Its offerings include Medicaid, Medicare, Medicare-Medicaid dual-eligible plans and health plans sold through government marketplaces under the Affordable Care Act.

The company’s services generally include medical care coordination, behavioral health support, pharmacy benefits and, depending on the plan and state, dental and vision benefits.